 Carlo Marchetti
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NLR Family, Pyrin Domain-Containing 3 Protein | 17 | 2024 | 166 | 4.910 |
Why?
| | Inflammasomes | 16 | 2024 | 144 | 3.640 |
Why?
| | Anti-Inflammatory Agents | 5 | 2020 | 478 | 1.760 |
Why?
| | Myocardial Reperfusion Injury | 7 | 2017 | 139 | 1.360 |
Why?
| | Carrier Proteins | 7 | 2016 | 729 | 1.230 |
Why?
| | Nitriles | 4 | 2021 | 211 | 1.180 |
Why?
| | Interleukin-1beta | 9 | 2024 | 389 | 0.910 |
Why?
| | Inflammation | 8 | 2024 | 2883 | 0.830 |
Why?
| | Interleukin-1 | 7 | 2024 | 961 | 0.800 |
Why?
| | Myeloid-Derived Suppressor Cells | 2 | 2021 | 76 | 0.780 |
Why?
| | Melanoma, Experimental | 2 | 2021 | 109 | 0.670 |
Why?
| | Myocardial Ischemia | 4 | 2016 | 285 | 0.670 |
Why?
| | Macrophages | 3 | 2018 | 1507 | 0.620 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2023 | 293 | 0.610 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 735 | 0.570 |
Why?
| | Arthritis, Reactive | 1 | 2018 | 7 | 0.560 |
Why?
| | Arthritis, Gouty | 1 | 2018 | 13 | 0.560 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 442 | 0.530 |
Why?
| | Arthritis, Experimental | 1 | 2018 | 136 | 0.490 |
Why?
| | Inflammation Mediators | 1 | 2019 | 507 | 0.490 |
Why?
| | Animals | 33 | 2024 | 38100 | 0.460 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2022 | 364 | 0.440 |
Why?
| | Dimethyl Sulfoxide | 1 | 2015 | 42 | 0.440 |
Why?
| | Pancreatic Neoplasms | 1 | 2023 | 928 | 0.440 |
Why?
| | Myocardial Infarction | 7 | 2017 | 1211 | 0.440 |
Why?
| | Mice | 23 | 2023 | 18357 | 0.410 |
Why?
| | Benzamides | 1 | 2014 | 226 | 0.380 |
Why?
| | Cardiovascular Agents | 4 | 2017 | 166 | 0.360 |
Why?
| | Caspase 1 | 6 | 2018 | 145 | 0.340 |
Why?
| | Sulfones | 4 | 2021 | 127 | 0.340 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 346 | 0.330 |
Why?
| | Mice, Inbred C57BL | 10 | 2023 | 5992 | 0.320 |
Why?
| | Interleukin-18 | 3 | 2018 | 234 | 0.310 |
Why?
| | Sulfonamides | 1 | 2014 | 583 | 0.310 |
Why?
| | Sepsis | 1 | 2015 | 664 | 0.270 |
Why?
| | Signal Transduction | 9 | 2024 | 5223 | 0.270 |
Why?
| | Cytokines | 4 | 2024 | 2069 | 0.270 |
Why?
| | Neoplasms | 1 | 2023 | 2913 | 0.270 |
Why?
| | Ventricular Function, Left | 6 | 2017 | 544 | 0.260 |
Why?
| | Peritonitis | 2 | 2019 | 83 | 0.240 |
Why?
| | Myocardial Reperfusion | 2 | 2017 | 56 | 0.240 |
Why?
| | alpha 1-Antitrypsin | 2 | 2017 | 104 | 0.230 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2015 | 394 | 0.210 |
Why?
| | Immune Tolerance | 2 | 2023 | 385 | 0.200 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2024 | 196 | 0.200 |
Why?
| | Myocardium | 3 | 2017 | 935 | 0.190 |
Why?
| | Receptors, Interleukin-1 Type I | 2 | 2020 | 25 | 0.180 |
Why?
| | Deoxycytidine | 1 | 2023 | 220 | 0.180 |
Why?
| | Mice, Knockout | 5 | 2021 | 3130 | 0.180 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 212 | 0.170 |
Why?
| | Cardiomyopathies | 2 | 2015 | 335 | 0.170 |
Why?
| | Interleukin-6 | 3 | 2021 | 779 | 0.170 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2019 | 253 | 0.160 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 611 | 0.160 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 206 | 0.150 |
Why?
| | Molecular Targeted Therapy | 2 | 2020 | 440 | 0.150 |
Why?
| | Lipopolysaccharides | 3 | 2018 | 858 | 0.150 |
Why?
| | Colitis | 1 | 2022 | 281 | 0.150 |
Why?
| | Immunity, Innate | 2 | 2016 | 835 | 0.140 |
Why?
| | Mice, Inbred ICR | 2 | 2016 | 113 | 0.140 |
Why?
| | Uric Acid | 1 | 2019 | 167 | 0.140 |
Why?
| | Drug Design | 1 | 2019 | 175 | 0.140 |
Why?
| | Cell Line, Tumor | 2 | 2023 | 3551 | 0.140 |
Why?
| | Stroke Volume | 3 | 2016 | 655 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2021 | 411 | 0.130 |
Why?
| | Intestinal Mucosa | 1 | 2023 | 675 | 0.130 |
Why?
| | Humans | 17 | 2024 | 145750 | 0.130 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2018 | 4151 | 0.130 |
Why?
| | Disease Models, Animal | 9 | 2020 | 4569 | 0.130 |
Why?
| | Male | 17 | 2020 | 72992 | 0.130 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2017 | 203 | 0.120 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2016 | 41 | 0.120 |
Why?
| | Dietary Sucrose | 1 | 2015 | 50 | 0.110 |
Why?
| | Myocarditis | 1 | 2016 | 102 | 0.110 |
Why?
| | Radiation Injuries, Experimental | 1 | 2015 | 20 | 0.110 |
Why?
| | Angiotensin II | 1 | 2015 | 102 | 0.110 |
Why?
| | Melanoma | 1 | 2021 | 761 | 0.110 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 923 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 468 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2020 | 630 | 0.100 |
Why?
| | Ventricular Remodeling | 2 | 2014 | 278 | 0.100 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 47 | 0.100 |
Why?
| | Diet, High-Fat | 1 | 2015 | 266 | 0.100 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2014 | 267 | 0.100 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2014 | 218 | 0.090 |
Why?
| | Doxorubicin | 1 | 2015 | 403 | 0.090 |
Why?
| | Repressor Proteins | 1 | 2014 | 429 | 0.080 |
Why?
| | Heart Failure | 2 | 2015 | 2326 | 0.080 |
Why?
| | Heart Diseases | 1 | 2014 | 341 | 0.080 |
Why?
| | Antibodies, Monoclonal | 2 | 2014 | 1505 | 0.080 |
Why?
| | Pericardium | 1 | 2009 | 59 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 72 | 0.070 |
Why?
| | Cell Line | 1 | 2014 | 2823 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2023 | 376 | 0.070 |
Why?
| | MicroRNAs | 1 | 2014 | 686 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2190 | 0.070 |
Why?
| | Tissue Survival | 2 | 2017 | 16 | 0.060 |
Why?
| | Time Factors | 4 | 2017 | 7133 | 0.050 |
Why?
| | Systole | 2 | 2015 | 181 | 0.050 |
Why?
| | Blood Glucose | 1 | 2014 | 2344 | 0.050 |
Why?
| | Caspase 3 | 2 | 2014 | 242 | 0.050 |
Why?
| | Myocardial Contraction | 2 | 2014 | 293 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2191 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2022 | 93 | 0.040 |
Why?
| | Interleukins | 1 | 2023 | 248 | 0.040 |
Why?
| | Organoids | 1 | 2023 | 145 | 0.040 |
Why?
| | Models, Immunological | 1 | 2021 | 99 | 0.040 |
Why?
| | Female | 5 | 2023 | 79025 | 0.040 |
Why?
| | Apoptosis | 3 | 2014 | 2443 | 0.040 |
Why?
| | Behavior Observation Techniques | 1 | 2020 | 10 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2022 | 2805 | 0.040 |
Why?
| | Presenilin-1 | 1 | 2020 | 34 | 0.040 |
Why?
| | Spatial Memory | 1 | 2020 | 27 | 0.040 |
Why?
| | Gene Deletion | 1 | 2022 | 392 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2020 | 64 | 0.040 |
Why?
| | Tumor Burden | 1 | 2021 | 325 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 644 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 630 | 0.040 |
Why?
| | Myocytes, Cardiac | 2 | 2014 | 546 | 0.040 |
Why?
| | Leukocytes | 1 | 2019 | 296 | 0.030 |
Why?
| | Microglia | 1 | 2020 | 273 | 0.030 |
Why?
| | Administration, Oral | 1 | 2020 | 867 | 0.030 |
Why?
| | Neuronal Plasticity | 1 | 2020 | 305 | 0.030 |
Why?
| | Pyrimidines | 1 | 2021 | 530 | 0.030 |
Why?
| | Pyrazoles | 1 | 2021 | 517 | 0.030 |
Why?
| | Cytoprotection | 1 | 2017 | 56 | 0.030 |
Why?
| | Behavior, Animal | 1 | 2020 | 520 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2020 | 474 | 0.030 |
Why?
| | Nitrites | 1 | 2017 | 88 | 0.030 |
Why?
| | Troponin I | 1 | 2017 | 73 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 859 | 0.030 |
Why?
| | Leukocyte Elastase | 1 | 2016 | 75 | 0.030 |
Why?
| | Infusions, Subcutaneous | 1 | 2015 | 23 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2017 | 782 | 0.030 |
Why?
| | Caspase 7 | 1 | 2014 | 22 | 0.030 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2015 | 141 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2017 | 231 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2014 | 91 | 0.030 |
Why?
| | Candida | 1 | 2014 | 46 | 0.030 |
Why?
| | Interleukin-1alpha | 1 | 2014 | 57 | 0.030 |
Why?
| | Isoproterenol | 1 | 2014 | 96 | 0.030 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2014 | 58 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 337 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1368 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 666 | 0.020 |
Why?
| | Sulfides | 1 | 2014 | 92 | 0.020 |
Why?
| | Histone Deacetylases | 1 | 2014 | 207 | 0.020 |
Why?
| | Fibrosis | 1 | 2015 | 561 | 0.020 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2012 | 124 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2014 | 574 | 0.020 |
Why?
| | Monocytes | 1 | 2014 | 539 | 0.020 |
Why?
| | Antibodies | 1 | 2014 | 397 | 0.020 |
Why?
| | Echocardiography | 1 | 2014 | 648 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 848 | 0.020 |
Why?
| | WT1 Proteins | 1 | 2009 | 12 | 0.020 |
Why?
| | Pericardial Effusion | 1 | 2009 | 22 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1218 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1118 | 0.020 |
Why?
| | Blood Pressure | 1 | 2015 | 1782 | 0.020 |
Why?
| | Rats | 1 | 2017 | 5585 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4302 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2933 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2009 | 2514 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2009 | 2051 | 0.010 |
Why?
| | Aged | 1 | 2009 | 26212 | 0.000 |
Why?
| | Middle Aged | 1 | 2009 | 36297 | 0.000 |
Why?
|
|
Marchetti's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|